Rituximab for opsoclonus myoclonus ataxia syndrome associated with neuroblastoma

Indian Journal of Pediatrics

Volumn 81, Issue 2, 2014, Pages 218-219

  Sinha, Shalini ^a   Sarin, Yogesh Kumar ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

CASE REPORT; CHILD; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; HUMAN; INFUSION RELATED REACTION; LETTER; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; OPSOCLONUS MYOCLONUS SYNDROME; PRESCHOOL CHILD; TREATMENT DURATION; TUMOR BIOPSY; TUMOR VOLUME; COMPLICATION; IMMUNOLOGY; INFANT; OPSOCLONUS-MYOCLONUS SYNDROME; SPINAL CORD TUMOR;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFANT; NEUROBLASTOMA; OPSOCLONUS-MYOCLONUS SYNDROME; SPINAL NEOPLASMS;

EID: 84898548292     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-013-1042-7     Document Type: Letter

References (5)

1. Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies-A report from the Children 's Cancer Group Study. Med Pediatr Oncol. 2001;36:612-22. (Pubitemid 32402157)
2. Matthay KK, Blaes F, Hero B, Plantaz D, De Alarcon P, Mitchell WG, et al. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004. Cancer Lett. 2005;228:275-82. (Pubitemid 41188452)
3. Mitchell WG, Davalos-Gonzalez Y, Brumm VL, Aller SK, Burger E, Turkel SB, et al. Opsoclonus-ataxia caused by childhood neuroblastoma: Developmental and neurologic sequelae. Pediatrics. 2002;109:86 - 98. Erratum in: Pediatrics 2002; 110:853-4.
4. Pranzatelli MR, Tate ED, Travelstead AL, Longee D. Immunologic and clinical responses to rituximab in a child with opsoclonusmyoclonus syndrome. Pediatrics. 2005;115:e115 -9.
5. Grillo-López AJ, White CA, Varns C, Shen D, Wei A, McClure A, et al. Overview of the clinical development of rituximab: First monoclonal antibody approved for the treatment of lymphoma. Semin Oncol. 1999;26:66-73. (Pubitemid 29523413)